Anabolic Therapy for the Treatment of Osteoporosis in Childhood.

Ward, Leanne M; Rauch, Frank

Ward, Leanne M; Rauch, Frank.

Affiliation

Ward LM; Department of Pediatrics, Faculty of Medicine, University of Ottawa and Division of Endocrinology and Metabolism, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, Ontario, K1H 8L1, Canada. lward@cheo.on.ca.
Rauch F; Department of Pediatrics, Faculty of Medicine, McGill University, and Shriners Hospital for Children, 1003 Boulevard Décarie, Montréal, Québec, H4A 0A9, Canada.

Curr Osteoporos Rep ; 16(3): 269-276, 2018 06.

Article in En | MEDLINE | ID: mdl-29589203

Subject(s)

Anabolic Agents/therapeutic use; Androgens/therapeutic use; Antibodies/therapeutic use; Bone Density Conservation Agents/therapeutic use; Human Growth Hormone/therapeutic use; Osteoporosis/drug therapy; Vibration/therapeutic use; Adaptor Proteins, Signal Transducing; Bone Morphogenetic Proteins/antagonists & inhibitors; Bone Morphogenetic Proteins/immunology; Child; Genetic Markers/immunology; Humans; Teriparatide/therapeutic use; Testosterone/therapeutic use; Transforming Growth Factor beta/antagonists & inhibitors; Transforming Growth Factor beta/immunology

Key words

Anabolic therapy; Androgen therapy; Anti-TGF-beta antibody; Anti-sclerostin antibody; Bone; Children; Fractures; Growth hormone; Parathyroid hormone; Testosterone; Whole body vibration therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteoporosis / Vibration / Human Growth Hormone / Bone Density Conservation Agents / Anabolic Agents / Androgens / Antibodies Limits: Child / Humans Language: En Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google